News & Updates

Vitiligo occurs as a cutaneous immune-related adverse event during immune checkpoint inhibitor (ICI) therapy in most melanoma and nonmelanoma cancer patients with partial or complete response to treatment, according to a systematic review.

At least 25 million individuals around the world are expected to live with Parkinson’s disease (PD) by the year 2050, posing a substantial public health challenge not just for patients and their families, but for caregivers, communities, and society as well, according to a study.

A considerable number of individuals who have received a diagnosis of major depressive disorder show little to no improvement despite having tried multiple antidepressant medications, according to new research.